The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Leadership - Oncology Hematology Care/US Oncology
Consulting or Advisory Role - Amgen; Pharmacyclics
Speakers' Bureau - Amgen; Celgene; Genentech; Merck; Pfizer

Practice transformation: Early impact of OCM on hospital admissions.
 
Molly Mendenhall
No Relationships to Disclose
 
Brian Bourbeau
Speakers' Bureau - Janssen Oncology
 
Karyn M. Dyehouse
Leadership - Oncology Hematology Care/US Oncology
Stock and Other Ownership Interests - Oncology Hematology Care/US Oncology
Honoraria - Pfizer
Research Funding - Genentech
 
Andrew S Guinigundo
No Relationships to Disclose
 
Teresa Meyer-Smith
No Relationships to Disclose
 
David Michael Waterhouse
Consulting or Advisory Role - Abbvie; Amgen; AZTherapies; Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly